PL2255799T3 - Środek do zwalczania ubocznych działań chemioterapii raka - Google Patents

Środek do zwalczania ubocznych działań chemioterapii raka

Info

Publication number
PL2255799T3
PL2255799T3 PL10004550T PL10004550T PL2255799T3 PL 2255799 T3 PL2255799 T3 PL 2255799T3 PL 10004550 T PL10004550 T PL 10004550T PL 10004550 T PL10004550 T PL 10004550T PL 2255799 T3 PL2255799 T3 PL 2255799T3
Authority
PL
Poland
Prior art keywords
combating
agent
side effects
cancer chemotherapy
chemotherapy
Prior art date
Application number
PL10004550T
Other languages
English (en)
Inventor
Stefanija Krug
Robert Schunk
Original Assignee
Robert Schunk
Stefanija Krug
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert Schunk, Stefanija Krug filed Critical Robert Schunk
Publication of PL2255799T3 publication Critical patent/PL2255799T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL10004550T 2009-04-30 2010-04-30 Środek do zwalczania ubocznych działań chemioterapii raka PL2255799T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009020314A DE102009020314A1 (de) 2009-04-30 2009-04-30 Mittel zur Bekämpfung von Nebenwirkungen der Krebs-Chemotherapie
EP10004550A EP2255799B1 (de) 2009-04-30 2010-04-30 Mittel zur Bekämpfung von Nebenwirkungen der Krebs-Chemotherapie

Publications (1)

Publication Number Publication Date
PL2255799T3 true PL2255799T3 (pl) 2012-10-31

Family

ID=42729435

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10004550T PL2255799T3 (pl) 2009-04-30 2010-04-30 Środek do zwalczania ubocznych działań chemioterapii raka

Country Status (6)

Country Link
EP (1) EP2255799B1 (pl)
DE (1) DE102009020314A1 (pl)
DK (1) DK2255799T3 (pl)
ES (1) ES2387550T3 (pl)
PL (1) PL2255799T3 (pl)
PT (1) PT2255799E (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2201942A1 (de) * 2008-12-23 2010-06-30 Intendis GmbH Zusammensetzung mit Hanföl für die Behandlung topischer Erkrankungen

Also Published As

Publication number Publication date
DK2255799T3 (da) 2012-08-27
EP2255799A1 (de) 2010-12-01
ES2387550T3 (es) 2012-09-26
DE102009020314A1 (de) 2010-11-04
PT2255799E (pt) 2012-08-16
EP2255799B1 (de) 2012-05-16

Similar Documents

Publication Publication Date Title
HK1245114A1 (zh) 癌症的抑制
EP2239264A4 (en) ANTITUMOR AGENT
EP2127671A4 (en) THERAPEUTIC AGENT AGAINST CANCER
EP2162149A4 (en) VACCINE FOR THE PREVENTION OF THE RECHUTE OF BREAST CANCER
HK1151734A1 (en) Therapeutic for hepatic cancer
EP2586443A4 (en) ANTICANCER AGENT USING COMPOUNDS HAVING COMBINED KINASE INHIBITING EFFECT
EP2241332A4 (en) THERAPEUTIC AGENT AGAINST PRITURE
GB201016139D0 (en) Cancer phosholipidome
IL202718A0 (en) Preventive/remedy for cancer
IL264349B1 (en) Regimens containing neratinib for the treatment of cancer
HK1223028A1 (zh) 預防乳腺癌復發的疫苗
EP2407165A4 (en) ANTIOXIDANTS
HK1141236A1 (en) Potentiation of cancer chemotherapy
SI2605764T1 (sl) Sestavki za zdravljenje raka
EP2283862A4 (en) CANCER AGENT
EP2617416A4 (en) MEANS TO INCREASE CANCER THERAPY
GB0918722D0 (en) Anti cancer agent
ZA201103627B (en) Prophylactic/therapeutic agent for cancer
EP2733140A4 (en) INDIRUBIN DERIVATIVE HAVING HIGHLY SELECTIVE CYTOTOXICITY FOR MALIGNANT TUMORS
EP2565192A4 (en) CANCER AGENT
EP2450352A4 (en) PROPHYLACTIC OR THERAPEUTIC ACTIVE AGAINST CANCER
EP2609927A4 (en) CELL PROTECTION PRODUCTS
EP2486929A4 (en) ANTI-TUMOR THERAPEUTIC AGENT
EP2502627A4 (en) ANTI CANCER AGENTS
AP2011005893A0 (en) Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer.